Press release
Accelerating Expansion in Hereditary Angioedema Therapeutics Market: Anticipated to Reach $16.11 Billion by 2029 at a CAGR of 19.7%
Hereditary Angioedema Therapeutics Market Share
Imminent growth in the Hereditary Angioedema Therapeutics Market is rooted in advancements in targeted therapies, global market expansion, and burgeoning sectors of gene therapy and personalized medicine.
What Is The Projected Market Size Of The Global Hereditary Angioedema Therapeutics Market And Its Growth Rate?
In the hereditary angioedema therapeutics market:
• The market has grown exponentially from $6.68 billion in 2024 to an expected $7.84 billion in 2025, marking a compound annual growth rate (CAGR) of 17.3%.
• The predicted market size is anticipated to reach an impressive $16.11 billion in 2029, showcasing a compound annual growth rate (CAGR) of 19.7%.
• The projected growth can be attributed to initiatives in patient advocacy and education, regulatory approvals, improved diagnosis, and increased treatment accessibility.
• The anticipated rapid growth is partially due to the combination of gene therapy developments, advancements in targeted therapies, personalized medicine trends, and global market expansion.
What Is Driving The Growth In The Hereditary Angioedema Therapeutics Market?
Hereditary angioedema, a rare genetic disorder characterized by severe swelling of the skin and mucous membranes, has experienced an upsurge in prevalence, prompting growth in the hereditary angioedema market. Estimates suggest 1 in 50,000 people globally suffer from this condition, contributing to between 15,000 and 30,000 annual emergency room visits in the US alone. The rise in prevalence of hereditary angioedema is therefore a key driving force behind the hereditary angioedema market.
Request A Free Sample Copy at
https://www.thebusinessresearchcompany.com/sample.aspx?id=10810&type=smp
Who Are the Key Players Driving Hereditary Angioedema Therapeutics Market Growth?
Key players in the hereditary angioedema therapeutics market include:
• Sanofi S.A.
• Pharming Healthcare Inc.
• Attune Pharmaceuticals Inc.
• Adverum Biotechnologies Inc.
• Arrowhead Pharmaceuticals Inc.
• Ionis Pharmaceuticals Inc.
• BioCryst Pharmaceuticals Inc.
• CSL Behring LLC
• KalVista Pharmaceutical Inc.
• CENTOGENE N.V.
What Are The Key Trends In The Hereditary Angioedema Therapeutics Market?
Major trends driving the forecast period include:
• Advancements in targeted therapies
• Global market expansion
• Developments in gene therapy
• The rise of personalized medicine trends
• Collaboration in research and treatment
What Are The Segments Of The Global Hereditary Angioedema Therapeutics Market?
The Hereditary Angioedema Therapeutics Market is segmented by:
• Drug Class: C1 Esterase Inhibitor, Selective Bradykinin B2 Receptor Antagonist, Kallikrein Inhibitor, Other Drug Classes
• Route of Administration: Intravenous, Subcutaneous, Oral
• Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels
• Application: Prophylaxis, On-demand
Which Region Leads The Hereditary Angioedema Therapeutics Market?
North America holds the largest share in the global hereditary angioedema therapeutics market as of 2024. However, Asia-Pacific is predicted to be the fastest-growing region in the forecast period. The report covers the hereditary angioedema therapeutics market across all regions including Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Pre-book the Report for Swift Delivery at
https://www.thebusinessresearchcompany.com/report/hereditary-angioedema-therapeutics-global-market-report
What Is Covered In The Hereditary Angioedema Therapeutics Market Global Market Report?
- Market Size Analysis: Analyze the Hereditary Angioedema Therapeutics Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Hereditary Angioedema Therapeutics Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Hereditary Angioedema Therapeutics Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Hereditary Angioedema Therapeutics Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Request Customization for This Report at
https://www.thebusinessresearchcompany.com/Customise?id=10810&type=smp
Learn More About The Business Research Company
The Business Research Company is a leading provider of in-depth research across 27 industries spanning 60+ countries worldwide. Housing over 15,000+ reports, the company has earned a reputation for delivering comprehensive, data-rich insights. Our key product, the Global Market Model (GMM), is the premier market intelligence platform providing comprehensive and real-time forecasts in support of informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Accelerating Expansion in Hereditary Angioedema Therapeutics Market: Anticipated to Reach $16.11 Billion by 2029 at a CAGR of 19.7% here
News-ID: 3831906 • Views: …
More Releases from The Business research company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Hereditary
Unraveling Hereditary Cancer With The Rising Demand For Hereditary Cancer Testin …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Hereditary Cancer Testing Industry Market Size Be by 2025?
The market encompassing hereditary cancer testing has exhibited robust expansion throughout the recent past, projecting an increase from its value of $4.32 billion in 2024 to reach $4.75 billion for the subsequent year, reflecting a consistent annual…
Leber Hereditary Optic Neuropathy Treatment Market
Introduction
Leber Hereditary Optic Neuropathy (LHON) is a genetic condition that leads to severe vision loss, primarily affecting young adults. This disorder is caused by mutations in mitochondrial DNA, which impairs the function of retinal ganglion cells. As awareness of LHON has grown, so too has the focus on its treatment options. The LHON treatment market is evolving rapidly, driven by advancements in genetic therapies, pharmaceuticals, and supportive care strategies. This…
Hereditary Hemochromatosis Market - Redefining Care, Inspiring Hope: Hereditary …
Newark, New Castle, USA: The "Hereditary Hemochromatosis Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Hereditary Hemochromatosis Market: https://www.growthplusreports.com/report/hereditary-hemochromatosis-market/8793
This latest report researches the industry structure, sales, revenue,…
Hereditary Angioedema Market Research Report 2032
DelveInsight's "Hereditary Angioedema Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the Hereditary Angioedema, historical and forecasted epidemiology as well as the Hereditary Angioedema market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Hereditary Angioedema (HAE) is a rare genetic disorder caused by the deficiency in functional C1 inhibitor (C1INH) that results in recurrent attacks of localized subcutaneous or…
Hereditary Angioedema - Drug Pipeline Landscape, 2022
Global Hereditary Angioedema Market report from Global Insight Services is the single authoritative source of intelligence on hereditary angioedema market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types,…
Hereditary Angioedema - Drug Pipeline Landscape, 2022
Hereditary Angioedema is an infrequent inherited disease that causes substantial swelling in various body tissues, such as the abdomen or face caused by a low level or improper function of a protein called the C1 inhibitor. There are three types of hereditary angioedema namely type I, II, and III.
Hereditary Angioedema is mainly caused by a low level or improper function of a protein called the C1 inhibitor.
Read more about Hereditary…
